Novartis, headquartered in Basel, Switzerland, is a global pharmaceutical company founded in 1996. The group employs approximately 109,000 people worldwide and develops innovative medicines that reach over 280 million patients globally. Its core activities span drug development, pharmaceutical research, and data management.
Unlike the venture-backed model typical of early-stage life sciences companies, Novartis operates at significant scale as a publicly listed entity within the pharmaceutical and healthcare verticals. The company's strategy centres on what it describes as "reimagining medicine" to improve and extend patients' lives, with a product pipeline focused on innovative therapeutics rather than generics.
For those exploring career paths at the intersection of capital allocation and healthcare innovation, Novartis represents the institutional end of the spectrum - a mature organisation with deep research capabilities and global commercial reach. The company culture signals point to collaboration and community as organisational values.
